Navigation Links
Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation
Date:6/8/2009

Clinical Specialists Provide Feedback on Current and Future Trends

MOUNTAIN VIEW, Calif., June 8 /PRNewswire/ -- A recent Frost & Sullivan end-user survey shows increased awareness and utilization of new tools and approaches to treating atrial fibrillation (Afib). Of the various forms of cardiac arrhythmia, AFib is the one of the most prevalent and hardest to treat. Two and a half million people in the U.S. have AFib, and about one million are symptomatic and do not respond well to traditional drug therapy and behavior modification (diet, exercise). Approximately 200,000 new cases of AFib are diagnosed annually in the U.S. While medical device therapy options are increasing, their adoption and utilization for atrial fibrillation has been slow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Market estimates show that less than 20 percent of the addressable market for atrial fibrillation therapy is being served due to limited regulatory approval and lack of provider training and expertise. The market that participants like to call "two years away, for the past ten years," is now building momentum due to ongoing clinical research and recent FDA approval of the first catheter ablation system for treatment of atrial fibrillation in February of 2009.

The latest end-user study from Frost & Sullivan's Medical Device group assesses a variety of critical dynamics of catheter ablation approaches and technologies in treatment of both paroxysmal and long-standing persistent atrial fibrillation. Electrophysiologists, cardiologists, and cardiac surgeons provided insight on factors such as adoption drivers, clinical preferences, expected impact of the economy, referral patterns, assistive technologies and brand perceptions.

Select findings include the following:


    '/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Frost & Sullivan Presents LG Electronics IRIS With the 2009 Global Iris Recognition Biometrics Market Customer Value Leadership of the Year Award
2. IT Budgets of Healthcare Organizations in Asia Pacific Region Expected to Grow, Regardless of the Economic Slowdown, says Frost & Sullivan
3. Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan
4. European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan
5. Frost & Sullivan: Healthcare Delivery in APAC Upon Economic Recession
6. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
7. Frost & Sullivan: SMBG Within Asia Pacific
8. Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan
9. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
10. Frost & Sullivan Cites Gearworks for Creativity and Customer Service in the Home Healthcare Market
11. Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 Raritan Bay Medical Center is ... an interactive photo contest held at the Woodbridge Center ... To raise awareness for health and wellness in the ... their best health and wellness tips. , Photos of ... Center’s website and Facebook page where Facebook users voted ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Claflin ... the Department of Veterans Affairs has signed a new, ... March 1, 2015. , Under the contract, the ... such as the U.S. Military, Indian Health Services, National ... local government entities with competitive pricing for hospital equipment ...
(Date:3/3/2015)... A newly launched program is available ... II diabetes, and pre-diabetes. As opposed to traditional pharmaceutical ... for diabetes sufferers to reverse their disease without the ... In 2013, the U.S. diabetes industry made $250 billion ... include the use of insulin and other glucose-controlling medications ...
(Date:3/3/2015)... T-System Inc. today announced ... CPHQ, FABC as the company’s chief nursing officer along ... episodic care. , “Today’s patients are demanding ... including urgent care and freestanding emergency centers one of ... Davis, T-System’s chief executive officer. “We have a ...
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
Breaking Medicine News(10 mins):Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
... looking into Tamiflu; Relenza also under scrutiny. , , ... Food and Drug Administration panel is meeting Tuesday ... flu drug Tamiflu (oseltamivir), linked recently to anecdotal ... , The FDA,s Pediatric Advisory Committee will begin ...
... STORZ OR1(R) GIVES SURGEONS, GREATER ACCESS TO PATIENT DATA AND ... ... REMOTELY, ALISO VIEJO, Calif., Nov. 27 Global Care Quest, ... Inc., the world leader in minimally invasive,endoscopic technologies and operating room integration, ...
... Nov. 27 Merge Healthcare (Nasdaq:,MRGE; TSX: ... services provider,announced today that its Merge Healthcare ... Gold Seal of Approval(TM), by demonstrating,compliance with ... national standard for healthcare quality and safety. ...
... million Series A financing from Alta Partners, ... ProQuest Investments and RiverVest Venture Partners, CARLSBAD, ... Pharmaceuticals, Inc. (Nasdaq: ISIS ) and Excaliard ... and develop antisense,drugs for the local treatment of ...
... green product design granted the International HIDO ... Award, TORONTO, and GOLFE JUAN, France, Nov. ... specializing in sustainable and health,product innovations and HIDO, ... has received the HIDO,International Design Award. The Award ...
... MAR, Calif., Nov. 27 ,Awake, the movie is a,psychological ... awareness" and finds himself awake and aware, but paralyzed,during heart ... ,Coma, captured and terrified,the American public,s imagination. ,Coma, is the ... surgery -- and never wake up again., "Five years ...
Cached Medicine News:Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 2Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 3Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 2Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 2Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 4Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 5Health News:Cooler Solutions' 'Dignity Toilet' Wins International Design Competition by Providing Sanitation for Those in Need 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 3
(Date:3/3/2015)... , March 3, 2015  3-D printing could ... treatments to individual patient needs, with clinicians having ... size and shape. That,s according to a study ... Radiology ,s Annual Scientific Meeting . Researchers ... filaments that were bioactive, giving these devices the ...
(Date:3/3/2015)... March 3, 2015  KaVo Kerr Group, a global ... new products at the 36 th International Dental ... Kerr Group delivers products and solutions to 99% of ... trade fair for the dental industry — the ideal ... to offer. The meeting, March 10-14, 2015, expects more ...
(Date:3/3/2015)... 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announces ... Executive Officer, will be making a corporate presentation at ... 8-11 in Dana Point, CA.  Dr. Ren will present ...
Breaking Medicine Technology:3-D printing offers innovative method to deliver medication 23-D printing offers innovative method to deliver medication 33-D printing offers innovative method to deliver medication 4KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 2KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 3CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2
... OXIS International, Inc., (OTC Bulletin Board: OXIS ... Executive Officer, and Bernie Landes, President, will present to ... Sciences & Medical Technologies On-Line Forum on Thursday, February ... A webcast of the presentation will be ...
... Hardy Diagnostics, an ISO certified biomedical firm, is pleased ... selective chromogenic medium recommended for use as a primary ... Salmonella and Shigella spp. from stool ... non-pathogenic enteric bacteria based on colony color. Differentiation of ...
Cached Medicine Technology:The Only Chromogenic Medium That Detects Both Salmonella and Shigella! 2
... Oxygen Conservation Device. Bypass ... ,6200 Accessories: , OCD870C ... CGA 540 Regulator , OCD2001-18 ... Booklet , CP2140 Vertical M-6 ...
... with Accutrol is similar in design to ... it incorporates a temperature probe at the ... probe can accurately determine the patient's core ... temperature accuracy comparable to a pulmonary artery ...
... These markers are available with 16 or 24 circular ... diameter, and an outer 9.5mm diameter. The markers are ... one single step for a 16 or 24 running ... points on the cornea to achieve a precise and ...
... Shafts For Insertion Through A 1.0mm Incision., ... ... A More Comfortable Approach., ,Recessed Jaws For ... For Protection Of Jaws During Sterilization., ,Reusable, ...
Medicine Products: